Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation

por Ugovšek, Sabina, Šebeštjen, Miran
Publicado 2021

Non-Lipid Effects of PCSK9 Monoclonal Antibodies on Vessel Wall

por Ugovšek, Sabina, Šebeštjen, Miran
Publicado 2022

Influence of lipid-lowering drugs on inflammation: what is yet to be done?

por Ugovšek, Sabina, Zupan, Janja, Rehberger Likozar, Andreja, Šebeštjen, Miran
Publicado 2021

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies

por Jeras, Jernej, Ugovšek, Sabina, Rehberger Likozar, Andreja, Šebeštjen, Miran
Publicado 2022

TNF-α Predicts Endothelial Function and Number of CD34(+) Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure

por Ugovšek, Sabina, Rehberger Likozar, Andreja, Finderle, Sanjo, Poglajen, Gregor, Okrajšek, Renata, Vrtovec, Bojan, Šebeštjen, Miran
Publicado 2022